One drop of blood is all it takes
to test for any biomarker at home

DEMOCRATIZING

CLINICAL DATA

Investors SARS-CoV-2

INVESTORS

About

The company has a product for blood biomarker testing. Customers demand this type of product and several contacts have already been made with vital institutions in Denmark. Sales for professional use are commenced in 2020.

Read more

Investors

Here you will find the share information for Qlife Holding AB. Our press releases and financial quarterly reports, our annual reports, calendar and information about our corporate governance work. Qlife Holding AB aims for a fast and transparent accounting to shareholders and the financial market.

The company is listed on Nasdaq, First North Growth Market, Stockholm as from March 2, 2020

Continue

Egoo.health

The Egoo product is a platform for accurate bio-marker testing. At a low cost and with equipment easy to use, it measures and analyses the patient’s blood. The patient can do the testing at home themselves. Read more on our product page.

Egoo.health

Contact

If you have any questions, please send us a message.

 

 

You agree by using this feature that your information is handled in accordance with applicable GDPR legislation.
11 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Interview with Thomas Warthoe
Interview with Peter Warthoe
Film - EGOO HEALTH EXPLAINED

In less than four minutes, CEO Thomas Warthoe explains what Egoo Health is all about, how it works and why it makes a difference for ordinary people, medical staff and health institutions. 

Read more about us

NEWS/PRESS

2021-01-07 08:00
Qlife CE-marks COVID-19 test

The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.

2020-12-22 10:59
Qlife raises loans of SEK 15 million to strengthen working capital ahead of the upcoming market launch.

Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.

2020-11-30 08:00
Qlife to increase decentralized testing of professional football in Denmark with Divisionsforeningen - Egoo.Health-platform placed in three clubs

Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.

2020-11-27 13:57
Qlife will not respond to preliminary rejection by the Danish Medicines Agency for COVID-19 test – focus on receiving CE-marking by year-end

On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th

2020-11-24 08:45
Qlife receives order for COVID-19 tests to European Women’s Handball Championship 2020

”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci

2020-11-19 11:30
Bulletin from the extraordinary shareholders’ meeting in Qlife Holding AB

Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants

2020-11-18 11:44
QLIFE HOLDING AB INTERIM REPORT Q3, 2020

FINANCIAL SUMMARY - THIRD QUARTER 2020

2020-11-13 17:55
Qlife: application for temporary approval in Denmark "in the interest of health protection" receives preliminary rejection by the Danish Medicines Agency

In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offer

2020-11-03 09:03
Nomination Committee appointed for Qlife Holding's Annual General Meeting 2021

The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes.